| Quartile 1 < 657.8pg/mL (n = 537) | Quartile 2 657.8 -797.7pg/mL (n = 510) | Quartile 3 797.8-958.2 pg/mL (n = 525) | Quartile 4 ≥ 958.3 pg/mL (n = 601) | Total (n = 2,173) | P-value for linear trend |
---|---|---|---|---|---|---|
Weighted number of participants | 10,242,822 | 10,232,107 | 10,227,089 | 10,270,606 | 40,972,624 | - |
Age, years | 68.1 (0.3) | 67.5 (0.3) | 67.1 (0.4) | 67.1 (0.2) | 67.4 (0.2) | 0.01 |
Female, n (%) | 271 (52.1) | 242 (49.9) | 269 (52.4) | 337 (57.9) | 1,119 (53.1) | 0.03 |
Race/ethnicity, n (%) | Â | Â | Â | Â | Â | 0.55 |
 Mexican Americans | 53 (3.6) | 54 (3.5) | 57 (3.9) | 67 (4.5) | 231 (3.9) |  |
 Other Hispanics | 44 (2.9) | 58 (3.6) | 68 (4.4) | 79 (4.9) | 249 (4.0) |  |
 Non-Hispanic Whites | 253 (79.4) | 232 (80.9) | 227 (79.7) | 218 (74.5) | 930 (78.6) |  |
 Non-Hispanic Blacks | 134 (8.2) | 114 (7.3) | 105 (6.5) | 175 (10.8) | 528 (8.2) |  |
 Other | 53 (5.8) | 52 (4.7) | 68 (5.5) | 62 (5.4) | 235 (5.4) |  |
Education, n (%) | Â | Â | Â | Â | Â | 0.45 |
 Below high school | 153 (17.4) | 151 (17.8) | 132 (13.1) | 155 (16.1) | 591 (16.1) |  |
 High school graduate | 125 (23.9) | 106 (19.5) | 114 (19.0) | 146 (23.8) | 491 (21.6) |  |
 Some college or above | 259 (58.7) | 253 (62.7) | 279 (68.0) | 300 (60.1) | 1,091 (62.4) |  |
CES-D score | 2.9 (0.2) | 2.8 (0.2) | 2.9 (0.3) | 2.8 (0.2) | 2.8 (0.1) | 0.81 |
Smoking status, n (%) | Â | Â | Â | Â | Â | 0.59 |
 Never | 249 (48.1) | 221 (46.6) | 262 (51.2) | 327 (50.1) | 1,059 (49.0) |  |
 Former | 211 (39.0) | 208 (42.2) | 191 (37.7) | 193 (35.6) | 803 (38.6) |  |
 Current | 77 (12.9) | 80 (11.2) | 72 (11.2) | 81 (14.4) | 310 (12.4) |  |
Body mass index, n (%) | Â | Â | Â | Â | Â | 0.15 |
 <18.5 kg/m2 | 6 (0.5) | 6 (1.2) | 5 (1.2) | 5 (1.5) | 22 (1.1) |  |
 18.5–24.9 kg/m2 | 120 (19.4) | 114 (22.0) | 125 (22.9) | 152 (25.5) | 511 (22.5) |  |
 25.0-29.9 kg/m2 | 187 (38.7) | 191 (39.0) | 183 (35.1) | 203 (34.2) | 764 (36.7) |  |
 ≥30 kg/m2 | 217 (41.3) | 194 (37.8) | 206 (40.8) | 238 (38.8) | 855 (39.7) |  |
Physical activity, hours/week | 1.1 (0.1) | 1.3 (0.1) | 1.4 (0.1) | 1.3 (0.1) | 1.3 (0.1) | 0.28 |
Stroke, n (%) | 42 (6.8) | 34 (6.2) | 31 (5.9) | 31 (4.1) | 138 (5.7) | 0.13 |
Prevalent coronary heart disease, n (%) | 50 (9.2) | 47 (9.3) | 42 (8.8) | 25 (4.8) | 164 (8.0) | 0.03 |
Total cholesterol, mg/dL | 190.9 (3.7) | 193.9 (3.5) | 195.9 (2.0) | 195.7 (2.6) | 194.1 (1.3) | 0.12 |
Systolic blood pressure, mmHg | 130.4 (1.3) | 130.7 (1.0) | 129.7 (1.3) | 131.0 (1.1) | 130.4 (0.5) | 0.89 |
CERAD W-L immediate recall | 19.9 (0.3) | 19.8 (0.3) | 20.1 (0.3) | 20.3 (0.3) | 20.0 (0.2) | 0.15 |
CERAD W-L delayed recall | 6.3 (0.2) | 6.4 (0.2) | 6.6 (0.2) | 6.5 (0.1) | 6.4 (0.1) | 0.10 |
Animal fluency test | 18.2 (0.3) | 18.6 (0.3) | 19.0 (0.4) | 18.2 (0.3) | 18.5 (0.2) | 0.72 |
Digit Symbol Substitution Test | 51.8 (0.9) | 54.7 (1.0) | 56.1 (1.1) | 54.8 (1.0) | 54.4 (0.6) | 0.02 |